Logo
  • Careers
  • Contact Us
  • Donate
  • Subscribe
Search
  • Home
  • About
    • About
    • Board of Directors
    • Senior Leadership
    • Financial Statements
    • Global Funding & Support
    • Our History: 1995-2021
  • Our Work
    • Our Work
    • Discovery & Research
      • Antibody Translational Research Program
      • Human Immunology Laboratory
      • IAVI Neutralizing Antibody Center
      • Vaccine Design and Development Laboratory
      • Clinical Research Centers
      • Clinical Research Standards
      • Observational Epidemiology Studies
      • IAVI in Africa
    • Translation & Product Development
    • Global Access to Scientific Innovations
    • ADVANCE
      • IAVI DataSpace
    • Advocacy & Community Engagement
      • CASPR
      • Tuberculosis R&D Advocacy
      • World Bank/Japan-supported
        Partnerships | 日本政府・世銀が支援するパートナーシップ
  • Our Science
    • Our Science
    • Pipeline
    • HIV Vaccines
    • bnAbs for HIV Prevention
    • Tuberculosis Vaccines
    • Emerging Infectious Diseases Vaccines
  • News & Resources
    • Latest NewsLatest News
    • Scientific Publications Scientific Publications
    • Press Releases
    • Features
    • IAVI Report
    • IAVI in the News
    • Fact Sheets & Publications
    • Vaccine Literacy Library
    • VOICES Newsletter
    • Multimedia
    • Media Contacts
    • Subscribe
  • Careers
  • Contact Us
  • Donate
  • Subscribe

Search

  • Home
  • About
    • About
    • Board of Directors
    • Senior Leadership
    • Financial Statements
    • Global Funding & Support
    • Our History: 1995-2021
  • Our Work
    • Our Work
    • Discovery & Research
    • Translation & Product Development
    • Global Access to Scientific Innovations
    • ADVANCE
    • Advocacy & Community Engagement
  • Our Science
    • Our Science
    • Pipeline
    • HIV Vaccines
    • bnAbs for HIV Prevention
    • Tuberculosis Vaccines
    • Emerging Infectious Diseases Vaccines
  • News & Resources
    • Latest NewsLatest News
    • Scientific Publications Scientific Publications
    • Press Releases
    • Features
    • IAVI Report
    • IAVI in the News
    • Fact Sheets & Publications
    • Vaccine Literacy Library
    • VOICES Newsletter
    • Multimedia
    • Media Contacts
    • Subscribe
  • Latest NewsLatest News
  • Scientific Publications Scientific Publications
  • Press Releases
  • Features
  • IAVI Report
  • IAVI in the News
  • Fact Sheets & Publications
  • Vaccine Literacy Library
  • VOICES Newsletter
  • Multimedia
  • Media Contacts
  • Subscribe

Latest News

Filter By:

eOD-GT8 protein
FEATURES
May 25, 2023

Novel HIV vaccine candidate stimulates immune response in T cells

MTBVAC - TB vaccine research
PRESS RELEASES
May 17, 2023

Zendal and IAVI announce expanded agreement to partner on development of TB vaccine candidate MTBVAC

Antibody molecule
FEATURES
May 10, 2023

New IAVI paper makes the case for strengthening clinical and regulatory pathways to accelerate global access to monoclonal antibodies

Press Releases

May 17, 2023

Zendal and IAVI announce expanded agreement to partner on development of TB vaccine candidate MTBVAC

March 2, 2023

IAVI and BARDA expand partnership to advance IAVI’s filovirus vaccine candidates

December 2, 2022

Scientists reveal encouraging findings in first-in-human clinical trial evaluating HIV vaccine approach

October 25, 2022

IAVI to accelerate promising investigational Sudan ebolavirus vaccine development for potential outbreak research and response

August 31, 2022

IAVI announces first vaccinations at Liberia site in Phase I clinical trial of Lassa fever vaccine candidate

See all Press Releases

Features

May 25, 2023

Novel HIV vaccine candidate stimulates immune response in T cells

May 10, 2023

New IAVI paper makes the case for strengthening clinical and regulatory pathways to accelerate global access to monoclonal antibodies

April 28, 2023

IAVI Board member Wafaa El-Sadr honored

March 30, 2023

IAVI leaders to participate in World Vaccine Congress

March 27, 2023

IAVI announces renewed support from the Danish government for its HIV prevention program

See all Features

Media Contacts

Africa

Ethel Makila
+254 71 904 3142
EMakila@iavi.org 

 

Europe

Hester Kuipers
+31 20 521 0343
HKuipers@iavi.org 

 

India

Smriti Bhagi
+91 11 4737 6025
SBhagi@iavi.org 

 

North America

Rose Catlos
+1 212 847 1049
RCatlos@iavi.org 

About

About

Board of Directors

Senior Leadership

Financial Statements

Global Funding & Support

Our History: 1995-2021

Our Work

Our Work

Discovery & Research

Translation & Product Development

Global Access to Scientific Innovations

ADVANCE

Advocacy & Community Engagement

Our Science

Our Science

Pipeline

HIV Vaccines

bnAbs for HIV Prevention

Tuberculosis Vaccines

Emerging Infectious Diseases Vaccines

News & Resources

Latest NewsLatest News

Scientific Publications Scientific Publications

Press Releases

Features

IAVI Report

IAVI in the News

Fact Sheets & Publications

Vaccine Literacy Library

VOICES Newsletter

Multimedia

Media Contacts

Subscribe

icon iaviIAVI guidestar platinum seal 2021 IAVI Charity Navigator 2021

Accessibility

Compliance/RFPs

Contact IAVI

Privacy Policy

Site Map

Supplier Diversity

Terms of Use

©2023 International AIDS Vaccine Initiative. International AIDS Vaccine Initiative®, IAVI®, and the IAVI logo® are registered trademarks of the International AIDS Vaccine Initiative, Inc.